Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma · Fase 2 · NCT07504588
Anti-VEGF Monoclonal Antibody, Bevacizumab, Biospecimen Collection, Carboplatin
National Cancer Institute (NCI) · Abrir el resumen
Malignant Female Reproductive System Neoplasm · Fase 2 · NCT06126276
Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test
National Cancer Institute (NCI) · Abrir el resumen
Cervical Cancer · Fase 2 · NCT05686226 · Artículos
E7 TCR-T cells, Aldesleukin
Christian Hinrichs · Abrir el resumen
Endometrial Adenocarcinoma · Fase 2 · NCT05112601
Biospecimen Collection, Computed Tomography, Ipilimumab, Magnetic Resonance Imaging
National Cancer Institute (NCI) · Abrir el resumen
Low-Grade Serous Ovarian Cancer · Fase 2 · NCT06394804
Avutometinib, Defactinib, Letrozole
Memorial Sloan Kettering Cancer Center · Abrir el resumen
Endometrioid Endometrial Adenocarcinoma · Fase 2 · NCT07107334
Glucagon-like peptide 1 receptor agonist
University of Florida · Abrir el resumen
Epithelial Ovarian Cancer · Fase 2 · NCT06890338
Carboplatin, Mirvetuximab Soravtansine, Bevacizumab
AbbVie · Abrir el resumen
Endometrial Cancer · Fase 2 · NCT07139977
Enfortumab Vedotin
William Bradley · Abrir el resumen
Endometrial Cancer · Fase 2 · NCT04774419
Intensity modulated radiation therapy (IMRT), Dostarlimab, Hypofractionated IMRT
Memorial Sloan Kettering Cancer Center · Abrir el resumen
Ovarian Cancer · Fase 2 · NCT07059845
Mirvetuximab Soravtansine, Bevacizumab, Carboplatin
AbbVie · Abrir el resumen
Uterine Leiomyosarcoma · Fase 2 · NCT07076186
Trabectedin, Doxorubicin Hydrochloride
M.D. Anderson Cancer Center · Abrir el resumen
Advanced Fallopian Tube Carcinoma · Fase 2 · NCT06639074
Biopsy, Biospecimen Collection, Computed Tomography, Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
Mayo Clinic · Abrir el resumen
Ovarian High Grade Serous Adenocarcinoma · Fase 2 · NCT05998135
Atovaquone, Biopsy, Computed Tomography, Paracentesis
Emory University · Abrir el resumen
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer · Fase 2 · NCT05128825
azenosertib
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc · Abrir el resumen
Recurrent Endometrial Cancer · Fase 2 · NCT07594015
Pembrolizumab, Lenvatinib
University of Miami · Abrir el resumen
Endometrial Cancer · Fase 2 · NCT06925724
Ivonescimab
Memorial Sloan Kettering Cancer Center · Abrir el resumen
Fallopian Tube Carcinoma · Fase 2 · NCT07495124
pUMVC3-hIGFBP-2 Multi-epitope Plasmid DNA Vaccine, Carboplatin, Computed Tomography, Magnetic Resonance Imaging
University of Washington · Abrir el resumen
Cervical Cancer · Fase 2 · NCT05758688
Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT)
Abramson Cancer Center at Penn Medicine · Abrir el resumen
Metastatic Cancer · Fase 2 · NCT05475171
Lorigerlimab
M.D. Anderson Cancer Center · Abrir el resumen
Ovarian Cancer · Fase 2 · NCT07023627
INCB123667
Incyte Corporation · Abrir el resumen
Ovarian Cancer · Fase 2 · NCT06787612
Ubamatamab, Bevacizumab, Cemiplimab, Fianlimab
Regeneron Pharmaceuticals · Abrir el resumen
Cervical Cancer · Fase 2 · NCT04865887
Pembrolizumab, Lenvatinib
Georgetown University · Abrir el resumen
Endometrial Adenocarcinoma · Fase 2 · NCT05548296
ACR-368, Gemcitabine, OncoSignature
Acrivon Therapeutics · Abrir el resumen
Ovarian Clear Cell Adenocarcinoma · Fase 2 · NCT05231122
Anti-CD40 Agonist Monoclonal Antibody CDX-1140, Bevacizumab, Pembrolizumab, Quality-of-Life Assessment
Roswell Park Cancer Institute · Abrir el resumen